Agent Orange and head and neck cancer: A systematic review and meta‐analysis by Neil P. Monaghan, Kelsey A. Duckett, Shaun A. Nguyen, Jason G. Newman, Alexandra E. Kejner, W. Greer Albergotti

Get full text

Neoadjuvant cytokine (IRX-2) immunotherapy for resectable oral cavity carcinoma: Final results of the INSPIRE trial by Gregory T. Wolf, Emily Bellile, Celine Mauquoi, Ariane Nguyen, Maureen Sartor, Siyu Liu, Laura Rozek, Jonathan B. McHugh, Jeff Moyer, Mihir Patel, Nabil Saba, Audrey Erman, Wanessa A. Martins, Jason G. Newman, Michael Kaplan, Frabicio Oliveira, Ana Paula Victorina, R. Bryan Bell, Gustavo C. Girotto, Jorge Nieva, Joseph Valentino, Greg Krempl, Claudio R. Cernea, Dennis Kraus, Kevin Higgins, Felipe JSM. Cruz, Aru Panwar, Clodoaldo Z. Campos, Jim McCaul

Get full text

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma by Angela J. Yoon, Richard D. Carvajal, Evan M. Graboyes, John M. Kaczmar, William G. Albergotti, Alexandra E. Kejner, Scott H. Troob, Elizabeth Philipone, Jean-Sebastien Anoma, Kent E. Armeson, Elizabeth G. Hill, Mary S. Richardson, Tina R. Woods, Bhishamjit S. Chera, Farzad Nourollah-Zadeh, Byung J. Lee, Subramanya Pandruvada, Antonis Kourtidis, Christina Kingsley, Elizabeth C. O’Quinn, Stephanie Mills, Victoria C. Jordan, Mike Spencer, Danielle Fails, Trevor D. McKee, Mark Zaidi, Alan Brisendine, Shane Horn, Shikhar Mehrotra, Besim Ogretmen, Jason G. Newman

Get full text